Price History

Hover for the daily close. The dotted line marks the period open.

Compare UTMD with… →

UTMD Key Statistics

As of Oct 21, 2026

Trading

Open: $75.08
Previous Close: $75.07
Day's Range: 74.69–75.09
52-Week Range: 53.66–76.89
Volume: 36.59K
Beta: 0.39

Valuation

Market Cap: $237.15M
P/E Ratio: 22.78
PEG Ratio: 4.25
P/S ratio: 6.57
EPS (ttm): 3.28

Financials (FY)

Revenue (FY): $38.52M−5.83%
Net Income (FY): $11.29M−18.65%
Profit margin: 29.04%
Shares Outstanding: 3.17M
1-Year Return: +25.46%

Dividend and dates

Dividend: $1.24+1.65%
Ex-Dividend Date: September 17, 2026
Earnings Date: October 22, 2026estimated
Avg Volume: 36.75K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

UTMD Stock Return by Calendar Year

Utah Medical Products, Inc. (UTMD) 10-year return: what $10,000 became

1 year: $10,000 $12,546; +25.46%
5 years: $10,000 $8,977; −10.23%
10 years: $10,000 $14,153; +41.53%

If you had invested $10,000 in Utah Medical Products, Inc. (UTMD) 10 years ago, at the close on October 21, 2016, it would have been worth $14,153 at the close on October 21, 2026: +41.53% in total, +3.53% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

−25.69%+34.79%

2016*2017201820192020202120222023202420252026*

Year	Return
2026 (partial year)	+34.79%
2025	−7.01%
2024	−25.69%
2023	−15.10%
2022	+1.87%
2021	+21.97%
2020	−20.87%
2019	+31.46%
2018	+3.24%
2017	+13.59%
2016 (partial year)	+14.35%

As of October 21, 2026.

UTMD Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$38.52M	$11.29M	29.3%
2024	$40.90M	$13.87M	33.9%
2023	$50.22M	$16.64M	33.1%
2022	$52.28M	$16.47M	31.5%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$38.52M	$22.00M	$11.40M	$11.29M	29.3%
2024	$40.90M	$24.14M	$13.59M	$13.87M	33.9%
2023	$50.22M	$30.04M	$16.78M	$16.64M	33.1%
2022	$52.28M	$32.20M	$19.79M	$16.47M	31.5%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

UTMD Dividend History

’16’17’18’19’20’21’22’23’24’25’26*

$1.23+1.7% vs 2024

Dividends per share, 2025 · 4 payments

Year	Dividends per share	Payments	Change
2026*	$0.93	3	—
2025	$1.23	4	+1.7%
2024	$1.21	4	+1.7%
2023	$1.19	4	+1.7%

Year	Dividends per share	Payments	Change
2026 (partial year)	$0.93	3	—
2025	$1.23	4	+1.7%
2024	$1.21	4	+1.7%
2023	$1.19	4	+1.7%
2022	$1.17	4	−59.2%
2021	$2.86	4	+153.8%
2020	$1.13	4	+1.8%
2019	$1.11	4	+1.8%
2018	$1.09	4	+1.9%
2017	$1.07	4	+301.9%
2016	$0.27	1	—

Most recent payment: $0.31 per share, ex-dividend September 17, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

UTMD Valuation vs Medical Instruments & Supplies Median

Median of 50 stocks

Metric	UTMD	Medical Instruments & Supplies median	vs median
P/E	22.78	31.19	27% below
P/S ratio	6.57	2.60	153% above
Profit margin	29.04%	1.62%	27.4 pts above

Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 7 articles ↓

Utah Medical Products: Healthy Cash Holdings, But Declining Revenue Is A Cause For Concern
SeekingAlpha2026-08-26

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Utah Medical Products, Inc. (UTMD) is capitalised at $237.15M on the latest close. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. The company reports 140 employees.

UTMD last closed at $74.72 on October 21, 2026. That is −$0.35 (−0.47%) against the previous close. Over the past 52 weeks the price has ranged from $53.66 to $76.89. The latest close sits 39.25% above that 52-week low.

Financial Health

In fiscal 2025, Utah Medical Products, Inc. reported revenue of $38.52M. That is −5.83% against the prior fiscal year, when revenue was $40.90M. The same year closed with net income of $11.29M. That is −18.65% against the prior fiscal year. Profit margin runs at 29.04%. That is 27.4 percentage points above the Medical Instruments & Supplies median of 1.62%. Earnings per share on a trailing basis come to 3.28.

Across the 4 fiscal years on file, revenue moves from $52.28M in 2022 to $38.52M in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 22.78 times earnings. That is 26.96% below the Medical Instruments & Supplies median of 31.19. The PEG ratio, which sets the P/E against expected earnings growth, reads 4.25. Measured against sales, the shares trade at 6.57 times revenue. On price-to-sales that is 152.82% above the Medical Instruments & Supplies median of 2.6. The medians here are taken across 50 Medical Instruments & Supplies companies that report the metric.

The reported beta is 0.39. Daily returns over the trailing 10 years annualize to a volatility of 31.1%. The trailing one-year total return is +25.46%. Across 10 years the annualized return works out at +3.53%.

Growth & Income

UTMD pays a dividend yielding 1.65%. That is 0.6 percentage points above the Medical Instruments & Supplies median yield of 1.04%. At the indicated rate that is $1.24 a share a year. The ex-dividend date on file is September 17, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $0.93 a share. The year before, 2025, totalled $1.23 a share.

Across the complete calendar years on file, 2019 returned +31.46% and 2024 returned −25.69%. Of the 9 complete calendar years on file, 5 finished higher. 2026 is still running; the total return is +34.79% year to date.

Peer Comparison

Utah Medical Products, Inc. (UTMD) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Utah Medical Products, Inc.	UTMD	$237.15M	22.8
Intuitive Surgical, Inc.	ISRG	$151.25B	51.8
Becton, Dickinson and Company	BDX	$52.79B	45.1
Medline Inc.	MDLN	$47.51B	88.3

The Medical Instruments & Supplies industry average P/E ratio is 31.2x. Utah Medical Products, Inc. trades at a P/E of 22.8.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$151.25B

BDX

Becton, Dickinson and Company

$52.79B

MDLN

Medline Inc.

$47.51B

RMD

ResMed Inc.

$34.63B

ALC

Alcon Inc.

$32.60B

WST

West Pharmaceutical Services, Inc.

$27.69B

View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

JNJ

Johnson & Johnson

$621.22B

ABBV

AbbVie Inc.

$503.27B

UNH

UnitedHealth Group Incorporated

$374.30B

MRK

Merck & Co., Inc.

$369.78B

View all Healthcare stocks →

About Utah Medical Products, Inc.

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; BioPharm HP-PRT; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health center in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Visit website →

Utah Medical Products, Inc. (UTMD) Stock Analysis